NCT02029625
Completed
Phase 1
A Clinical Trial to Compare the Pharmacokinetics and Safety of NVP-1205 and Coadministration of Rosuvastatin and Ezetimibe in Healthy Male Volunteers
NVP Healthcare1 site in 1 country41 target enrollmentFebruary 2014
ConditionsDyslipidemia
Overview
- Phase
- Phase 1
- Intervention
- NVP-1205
- Conditions
- Dyslipidemia
- Sponsor
- NVP Healthcare
- Enrollment
- 41
- Locations
- 1
- Primary Endpoint
- AUClast
- Status
- Completed
- Last Updated
- 10 years ago
Overview
Brief Summary
The purpose of this study is to compare the pharmacokinetics of NVP-1205 and coadministration of rosuvastatin and ezetimibe.
Detailed Description
rosuvastatin and ezetimibe(anti-dyslipidemia)
Investigators
Eligibility Criteria
Inclusion Criteria
- •Healthy male subjects age between 19 and 55 signed informed consent
Exclusion Criteria
- •subjects have a history of allergy reaction of this drug or other drugs
Arms & Interventions
NVP-1205
administration of NVP-1205(rosuvastatin+ezetimibe)
Intervention: NVP-1205
rosuvastatin and ezetimibe
coadministration of rosuvastatin and ezetimibe
Intervention: rosuvastatin and ezetimibe
Outcomes
Primary Outcomes
AUClast
Time Frame: 0-96hr
Secondary Outcomes
- AUCinf(0-96hr)
Study Sites (1)
Loading locations...
Similar Trials
Completed
Phase 1
Compare the Pharmacokinetics of NVP-1805 and Coadministration of NVP-1805-R1 With NVP-1805-R2HealthyNCT04780386NVP Healthcare58
Completed
Phase 1
NVP-1805 Compared to Coadministration of NVP-1805-R1 With NVP-1805-R2 in Healthy Adult Volunteers (BE)Healthy VolunteersNCT05354713NVP Healthcare58
Completed
Phase 1
A Study to Evaluate the Safety and Pharmacokinetics of NVP-1402HealthyNCT02897726NVP Healthcare38
Completed
Phase 1
Pharmacokinetic Interaction and Safety Between NVP-1203-R1 and NVP-1203-R2HealthyNCT04181437NVP Healthcare40
Completed
Phase 1
NVP-1805 Compared to Coadministration of NVP-1805-R1 With NVP-1805-R2 in Healthy Adult VolunteersHealthy VolunteersNCT04905342NVP Healthcare58